In a move to both strengthen and diversify the clinical research workforce, ACRP today announced a collaboration with Merck to provide access to training for clinical research sites located in historically underrepresented communities and for students interested in the clinical research profession.
In the turbulent waters of the clinical research workforce, with high turnover and burnout circling like relentless sharks, several leading organizations have found ways to navigate their way through and around the worst of the storm.
It is crucial to improve diversity, equity, and inclusion (DEI) in clinical trials for the health and well-being of everyone.
While oncology has been slower to adopt decentralized clinical trials than other medical specialties, many oncologists realize this type of service could be a game-changer for cancer research and treatments.
Though vaccine developers rapidly adopted decentralized clinical trials during the pandemic, today there is a surprisingly slow uptake of novel technologies across vaccine studies compared to other therapy areas.